News & Updates

Thromboprophylaxis with low molecular weight heparin (LMWH) appears to protect against the onset of superimposed pre-eclampsia, independently from aspirin use, reports a recent study.

Treatment with estetrol/drospirenone appears to be safe and efficacious in Japanese women with primary and secondary dysmenorrhea, according to a study.

The first-in-class monoclonal antibody bentracimab effectively and safely reverses the antiplatelet effects of ticagrelor in patients with an indication for urgent or emergent surgery or with major bleeding in the single-arm phase III REVERSE-IT trial.

Adding atezolizumab to the combination of trastuzumab plus capecitabine and oxaliplatin chemotherapy (XELOX) helps improve treatment response in patients with ERBB2-positive locally advanced resectable gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma, according to the results of the open-label phase II trial conducted in China.

Inflammaging plays no significant role in rheumatic immune-related adverse events (Rh-irAEs), as shown by the comparable numbers of overall irAEs and the severity of RH-irAEs between older and younger patients who developed these conditions after treatment with immune checkpoint inhibitors (ICIs), a study has shown.